Tuesday, May 16, 2017 4:46:26 PM
Lets remember only one thing changed, a few board members. What remains the same is:
Company sells shares to survive, not product. Not one product has been sold despite exes of $100M on admin, costs and a bit of R&D.
Company LIES to sell shares. Check our previous iterations of said device which was ready for sale, for sale, being sold: all dropped.
Company DECEIVES on status of agreements with other companies. Nothing clear said on KMI or others leaving a very wide open space for fantasy building.
Board Members given golden parachutes despite NO SALES and NO PERFORMANCE (Kyte, Bigger)
NO Peer support, a maverick researcher, no independent testing for the devices purported for sale, and results which are agreed to be inconclusive.
ADMISSION that the devices are not proven to the SEC.
Caveat Emptor: this stock is a scam.
Recent QSEP News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2024 08:39:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/05/2023 01:05:12 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 11:52:03 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM